Perspective Therapeutics Inc logo

Perspective Therapeutics Inc

AMEX:CATX (USA)  
$ 1.60 +0.07 (+4.58%) 10:08 PM EST
At Loss
P/B:
4.08
Market Cap:
$ 996.21M
Enterprise V:
$ 818.44M
Volume:
5.53M
Avg Vol (2M):
5.88M
Also Trade In:
Volume:
5.53M
At Loss
Avg Vol (2M):
5.88M

Business Description

Perspective Therapeutics Inc logo
Perspective Therapeutics Inc
NAICS : 339112 SIC : 5047
ISIN : US46489V1044
Description
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Name Current Vs Industry Vs History
Cash-To-Debt 62.77
Equity-to-Asset 0.83
Debt-to-Equity 0.01
Debt-to-EBITDA -0.07
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.78
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.56
9-Day RSI 43.36
14-Day RSI 49.16
6-1 Month Momentum % 449.58
12-1 Month Momentum % 215.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.98
Quick Ratio 12.98
Cash Ratio 12.46
Days Inventory 193.31
Days Payable 747.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -59.9
Shareholder Yield % -5.64

Financials (Next Earnings Date:2024-08-09 Est.)

CATX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CATX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Perspective Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) -1.83
EPS (TTM) ($) -0.19
Beta 2.48
Volatility % 136.37
14-Day RSI 49.16
14-Day ATR ($) 0.152671
20-Day SMA ($) 1.692
12-1 Month Momentum % 215.19
52-Week Range ($) 0.205 - 1.905
Shares Outstanding (Mil) 622.63

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Perspective Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Perspective Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Perspective Therapeutics Inc Frequently Asked Questions

What is Perspective Therapeutics Inc(CATX)'s stock price today?
The current price of CATX is $1.60. The 52 week high of CATX is $1.91 and 52 week low is $0.21.
When is next earnings date of Perspective Therapeutics Inc(CATX)?
The next earnings date of Perspective Therapeutics Inc(CATX) is 2024-08-09 Est..
Does Perspective Therapeutics Inc(CATX) pay dividends? If so, how much?
Perspective Therapeutics Inc(CATX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1